ATE397017T1 - Verfahren zur herstellung von insulinvorläufern und von analogen von insulinvorläufern - Google Patents
Verfahren zur herstellung von insulinvorläufern und von analogen von insulinvorläufernInfo
- Publication number
- ATE397017T1 ATE397017T1 AT00981169T AT00981169T ATE397017T1 AT E397017 T1 ATE397017 T1 AT E397017T1 AT 00981169 T AT00981169 T AT 00981169T AT 00981169 T AT00981169 T AT 00981169T AT E397017 T1 ATE397017 T1 AT E397017T1
- Authority
- AT
- Austria
- Prior art keywords
- insulin precursors
- precursors
- insulin
- analogues
- precursor analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199901868 | 1999-12-29 | ||
DKPA200000440 | 2000-03-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE397017T1 true ATE397017T1 (de) | 2008-06-15 |
Family
ID=26066172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00981169T ATE397017T1 (de) | 1999-12-29 | 2000-12-04 | Verfahren zur herstellung von insulinvorläufern und von analogen von insulinvorläufern |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1246845B1 (de) |
JP (1) | JP4773023B2 (de) |
KR (1) | KR20030004317A (de) |
CN (1) | CN100432104C (de) |
AT (1) | ATE397017T1 (de) |
AU (1) | AU1850601A (de) |
BR (1) | BR0016867A (de) |
CA (1) | CA2392840C (de) |
DE (1) | DE60039074D1 (de) |
ES (1) | ES2307544T3 (de) |
HU (1) | HUP0203475A3 (de) |
RU (1) | RU2283846C2 (de) |
WO (1) | WO2001049742A1 (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7105314B2 (en) | 2001-04-02 | 2006-09-12 | Novo Nordisk A/S | Method for making human insulin precursors |
WO2002079250A1 (en) * | 2001-04-02 | 2002-10-10 | Novo Nordisk A/S | Insulin precursors and a process for their preparation |
CA2464616C (en) | 2001-11-19 | 2012-07-24 | Are Bogsnes | Process for preparing insulin compounds |
WO2004085472A1 (en) * | 2003-03-27 | 2004-10-07 | Novo Nordisk A/S | Method for making human insulin precursors and human insulin |
WO2005054291A1 (en) * | 2003-12-03 | 2005-06-16 | Novo Nordisk A/S | Single-chain insulin |
CN100460508C (zh) * | 2004-11-03 | 2009-02-11 | 马延高 | 人胰岛素基因在甲醇酵母中的分泌表达方法 |
ES2558930T3 (es) | 2007-08-13 | 2016-02-09 | Novo Nordisk A/S | Análogos de la insulina de acción rápida |
JP5721432B2 (ja) | 2007-08-15 | 2015-05-20 | ノボ・ノルデイスク・エー/エス | アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン |
WO2009022013A1 (en) | 2007-08-15 | 2009-02-19 | Novo Nordisk A/S | Insulin analogues with an acyl and aklylene glycol moiety |
ES2563553T3 (es) | 2008-04-01 | 2016-03-15 | Novo Nordisk A/S | Conjugados de insulina-albúmina |
US8815798B2 (en) | 2010-06-23 | 2014-08-26 | Novo Nordisk A/S | Insulin analogues containing additional disulfide bonds |
RU2598273C2 (ru) | 2010-06-23 | 2016-09-20 | Ново Нордиск А/С | Производные инсулина, содержащие дополнительные дисульфидные связи |
WO2011161083A1 (en) | 2010-06-23 | 2011-12-29 | Novo Nordisk A/S | Human insulin containing additional disulfide bonds |
WO2012171994A1 (en) | 2011-06-15 | 2012-12-20 | Novo Nordisk A/S | Multi substituted insulins |
RU2014127270A (ru) * | 2011-12-15 | 2016-02-10 | Шанхай Хэнжуй Фармасьютикал Ко., Лтд. | Аналог человеческого инсулина и его ацилированное производное |
JP2016521701A (ja) | 2013-06-07 | 2016-07-25 | ノヴォ ノルディスク アー/エス | 成熟インスリンポリペプチドを作製するための方法 |
CN105087724B (zh) * | 2014-05-04 | 2019-12-03 | 重庆派金生物科技有限公司 | 酵母重组表达门冬胰岛素的制备方法 |
CN107417787B (zh) * | 2016-05-23 | 2020-11-17 | 江苏恒瑞医药股份有限公司 | 一种人松弛素2类似物的制备方法 |
CN107446039B (zh) * | 2016-05-31 | 2021-11-12 | 江苏恒瑞医药股份有限公司 | 一种人胰岛素类似物前体及其制备方法 |
CN106699872B (zh) * | 2016-12-27 | 2019-12-24 | 江南大学 | 一种提高胰岛素前体产量的方法 |
MX2020001434A (es) | 2017-08-17 | 2020-03-20 | Novo Nordisk As | Analogos de insulina acilados novedosos y usos de estos. |
CN108148114B (zh) * | 2017-12-08 | 2020-05-15 | 珠海冀百康生物科技有限公司 | 一种提高重组小分子蛋白表达量的串联前导肽及方法 |
CN108929370B (zh) * | 2018-07-15 | 2021-06-25 | 渤海大学 | 三种具有ace抑制活性的鸡蛋源活性肽 |
EP3852873A1 (de) | 2018-09-19 | 2021-07-28 | Ziylo Ltd | Glucose-empfindliche insuline und verwendungen davon |
CN113773392B (zh) * | 2020-06-09 | 2023-04-07 | 宁波鲲鹏生物科技有限公司 | 一种甘精胰岛素的制备方法 |
WO2022090448A1 (en) | 2020-10-30 | 2022-05-05 | Novo Nordisk A/S | Novel acylating reagents |
WO2023144240A1 (en) | 2022-01-26 | 2023-08-03 | Novo Nordisk Research Centre Oxford Limited | Glucose sensitive insulin derivatives and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK58285D0 (da) * | 1984-05-30 | 1985-02-08 | Novo Industri As | Peptider samt fremstilling og anvendelse deraf |
WO1995016708A1 (en) * | 1993-12-17 | 1995-06-22 | Novo Nordisk A/S | Proinsulin-like compounds |
KR0150565B1 (ko) * | 1995-02-15 | 1998-08-17 | 김정재 | 유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조방법 |
-
2000
- 2000-12-04 WO PCT/DK2000/000665 patent/WO2001049742A1/en active IP Right Grant
- 2000-12-04 CA CA2392840A patent/CA2392840C/en not_active Expired - Fee Related
- 2000-12-04 AT AT00981169T patent/ATE397017T1/de not_active IP Right Cessation
- 2000-12-04 HU HU0203475A patent/HUP0203475A3/hu unknown
- 2000-12-04 ES ES00981169T patent/ES2307544T3/es not_active Expired - Lifetime
- 2000-12-04 BR BR0016867-0A patent/BR0016867A/pt not_active Application Discontinuation
- 2000-12-04 RU RU2002120512/13A patent/RU2283846C2/ru not_active IP Right Cessation
- 2000-12-04 AU AU18506/01A patent/AU1850601A/en not_active Abandoned
- 2000-12-04 JP JP2001550282A patent/JP4773023B2/ja not_active Expired - Fee Related
- 2000-12-04 CN CNB008179603A patent/CN100432104C/zh not_active Expired - Lifetime
- 2000-12-04 DE DE60039074T patent/DE60039074D1/de not_active Expired - Lifetime
- 2000-12-04 EP EP00981169A patent/EP1246845B1/de not_active Expired - Lifetime
- 2000-12-04 KR KR1020027008588A patent/KR20030004317A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2002120512A (ru) | 2004-01-27 |
CA2392840A1 (en) | 2001-07-12 |
HUP0203475A2 (hu) | 2003-02-28 |
EP1246845B1 (de) | 2008-05-28 |
WO2001049742A1 (en) | 2001-07-12 |
DE60039074D1 (de) | 2008-07-10 |
PL355871A1 (en) | 2004-05-31 |
RU2283846C2 (ru) | 2006-09-20 |
KR20030004317A (ko) | 2003-01-14 |
HUP0203475A3 (en) | 2005-11-28 |
BR0016867A (pt) | 2002-10-08 |
CN1414974A (zh) | 2003-04-30 |
JP4773023B2 (ja) | 2011-09-14 |
CA2392840C (en) | 2012-07-17 |
AU1850601A (en) | 2001-07-16 |
JP2003518945A (ja) | 2003-06-17 |
EP1246845A1 (de) | 2002-10-09 |
ES2307544T3 (es) | 2008-12-01 |
CN100432104C (zh) | 2008-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE397017T1 (de) | Verfahren zur herstellung von insulinvorläufern und von analogen von insulinvorläufern | |
HK1022701A1 (en) | Exendin analogues, processes for their preparationand medicaments containing them exendin. | |
AU2003264419A1 (en) | Kdr peptides and vaccines containing the same | |
ATE443082T1 (de) | Insulinvorstufen und verfahren zu deren herstellung | |
ZA967173B (en) | Purified coprinus laccases and nucleic acids and encoding same | |
HUP0202755A2 (hu) | C-peptid inzulin és inzulinanalógok jobb előállítására | |
DE69104280D1 (de) | Verfahren zur Herstellung von hochreiner Isophthalsäure. | |
ATE169678T1 (de) | Stabilisierte enzyme | |
DE58903388D1 (de) | Verfahren zur herstellung von fluorierten carbonsaeurefluoriden. | |
ATE349528T1 (de) | Transkriptionsaktivator prtt aus dem pilz aspergillus niger verwendbar in verfahren zur herstellung von polypeptiden | |
ATE474930T1 (de) | Verfahren zur herstellung von insulinvorläufern und analogen von insulinvorläufern mit verbesserter fermentationsausbeute in hefe | |
AU2099301A (en) | Method for obtaining proteins having improved functional characteristics | |
DE69413946T2 (de) | Verfahren zur Herstellung von hochreiner 2,6-Naphthalindicarbonsäure | |
DE69925992D1 (de) | VERFAHREN ZUR HERSTELLUNG VON 5-HYDROXYBENZO[b]THIOPHEN-3-CARBONSÄURE | |
ATE47880T1 (de) | Vorlaeufer eines an dem c-ende amidierten peptids und dessen herstellung. | |
DE69530647D1 (de) | Für biosynthetische Insulinvorstufen kodierende DNA-Sequenzen und Verfahren zur Herstellung von Insulin | |
DE69331565D1 (de) | Ein verbessertes Verfahren zur Herstellung von 1,3-Butylenglykol | |
DE59503776D1 (de) | Cyclohexapeptide und deren Mischungen, Verfahren zur Herstellung sowie deren Verwendung | |
SE9503379D0 (sv) | A modified GAD, a method for producing a modified GAD, a method for supplying a modified GAD, a peptide and the use of an ordinary and/or a modified GAD | |
AR018532A1 (es) | Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas | |
AU4955296A (en) | Dna encoding protein kinase | |
ATE301199T1 (de) | Beta-primeverosidase gen | |
RU93032510A (ru) | Способ получения полиэфируретана в растворе этилацетата |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |